Literature DB >> 8539334

Benzodiazepine (omega) receptor partial agonists and the acquisition of conditioned fear in mice.

D J Sanger1, D Joly, G Perrault.   

Abstract

It is well established that benzodiazepines can produce anterograde amnesia in humans and interfere with the acquisition of passive avoidance and spatial responses in rodents. However, the extent to which the disruption of learning is a secondary effect of the sedation produced by these drugs has not been clearly established. In order to investigate this question, the effects of several BZ (omega) receptor partial agonists were studied on the acquisition of conditioned fear (passive avoidance learning) in mice. As these drugs have been shown to produce anticonvulsant and anxiolytic-like effects without sedation or depression of motor activity, it was of interest to see whether they could disrupt learning. Clear effects on the acquisition of conditioned fear were produced by imidazenil (0.01-1.0 mg/kg), divaplon (1-60 mg/kg), ZK 91296 (3-60 mg/kg), and Ro 17-1812 (0.1-10 mg/kg). However, bretazenil (0.1-10 mg/kg) did not produce statistically significant effects. Only the high dose of imidazenil (1.0 mg/kg) decreased levels of exploratory behaviour. These results show that BZ (omega) receptor partial agonists without apparent sedative actions can disrupt fear learning, indicating that the effects of this class of drugs on passive avoidance learning can be dissociated from sedation. The reasons for the observed differences between the different compounds studied are unclear at present and may be related to differences in intrinsic activity or receptor subtype selectivity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8539334     DOI: 10.1007/bf02245596

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  26 in total

1.  Pharmacological characterization of benzodiazepine receptor ligands with intrinsic efficacies ranging from high to zero.

Authors:  J R Martin; P Schoch; F Jenck; J L Moreau; W E Haefely
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

2.  The comparative effects of benzodiazepines, progabide and PK 9084 on acquisition of passive avoidance in mice.

Authors:  C L Broekkamp; M Le Pichon; K G Lloyd
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

3.  Benzodiazepine blockade of passive-avoidance task in mice: a state-dependent phenomenon.

Authors:  J B Patel; V B Ciofalo; L C Iorio
Journal:  Psychopharmacology (Berl)       Date:  1979-03-14       Impact factor: 4.530

4.  The free-exploratory paradigm: an effective method for measuring neophobic behaviour in mice and testing potential neophobia-reducing drugs.

Authors:  G. Griebel; C. Belzung; R. Misslin; E. Vogel
Journal:  Behav Pharmacol       Date:  1993-12       Impact factor: 2.293

5.  Anxiolytic drugs and the acquisition of conditioned fear in mice.

Authors:  D J Sanger; D Joly
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

6.  Effect of a new anxiolytic, DN-2327, on learning and memory in rats.

Authors:  T Wada; N Fukuda
Journal:  Pharmacol Biochem Behav       Date:  1992-03       Impact factor: 3.533

7.  Full and partial agonism displayed by benzodiazepine receptor ligands at recombinant gamma-aminobutyric acidA receptor subtypes.

Authors:  F Knoflach; U Drescher; L Scheurer; P Malherbe; H Mohler
Journal:  J Pharmacol Exp Ther       Date:  1993-07       Impact factor: 4.030

8.  Molecular mechanisms of the partial allosteric modulatory effects of bretazenil at gamma-aminobutyric acid type A receptor.

Authors:  G Puia; I Ducic; S Vicini; E Costa
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

Review 9.  Novel anxiolytics that act as partial agonists at benzodiazepine receptors.

Authors:  W Haefely; J R Martin; P Schoch
Journal:  Trends Pharmacol Sci       Date:  1990-11       Impact factor: 14.819

10.  Chronic use of benzodiazepines and psychomotor and cognitive test performance.

Authors:  I Lucki; K Rickels; A M Geller
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

View more
  1 in total

1.  A mouse model of high trait anxiety shows reduced heart rate variability that can be reversed by anxiolytic drug treatment.

Authors:  Stefano Gaburro; Oliver Stiedl; Pietro Giusti; Simone B Sartori; Rainer Landgraf; Nicolas Singewald
Journal:  Int J Neuropsychopharmacol       Date:  2011-02-15       Impact factor: 5.176

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.